Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking ...

Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulator ...

QCi will leverage its expertise with TFLN to integrate the high-performance 400G/Lane modulators with the POET Optical Interposer™ platform technology. When complete, the engine will provide ...

POET Technologies Inc. (NASDAQ:POET) shares rose 2.3% in premarket trading Tuesday after the company announced a strategic ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight, creator of the TFLN Chiplet™ platform, today announced the launch of its groundbreaking 110 GHz Low Vπ Intensity Modulator, featuring industry-standard ...

Swave Photonics, the true holographic display company, today announced that its Holographic eXtended Reality (HXR) Spatial ...

US biotech Dewpoint Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...